Baseline Serum Cholesterol Levels Predict the Response of Patients with Advanced Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitor-Based Treatment

PURPOSE: Although predictive markers of immune checkpoint inhibitor (ICI)-based treatments have been extensively studied, with the exception of programmed death ligand 1 (PD-L1), most are not widely used in the clinic due to poor effects or defective practicability. The aim of this study was to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Jingtao, Mao, Yifei, Yang, Ziru, Xu, Quan, Zheng, Zhen, Zhang, Hui, Wang, Jingjing, Zhang, Sandian, Rong, Weibo, Zheng, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140899/
https://www.ncbi.nlm.nih.gov/pubmed/34040444
http://dx.doi.org/10.2147/CMAR.S304022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140899/
https://www.ncbi.nlm.nih.gov/pubmed/34040444
http://dx.doi.org/10.2147/CMAR.S304022

Ejemplares similares